Who
Christopher Causey
Director
Company insider
Files Form 4 as: Director, United Therapeutics.
In numbers
- Trades disclosed
- 578
- Buys
- 0
- Sells
- 103
- Bought
- $0
- Sold
- $28.8M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 29 Dec 2005
- Last trade
- 22 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,380 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,380 at $0.00 | filing |
| 30 Mar 2026filed 31 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $156K1,300 at $119.76 | filing |
| 30 Mar 2026filed 31 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $786K1,300 at $604.64 | filing |
| 30 Mar 2026filed 31 Mar 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,300 at $0.00 | filing |
| 30 Mar 2026filed 31 Mar 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,300 at $0.00 | filing |
| 30 Mar 2026filed 31 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $156K1,300 at $119.76 | filing |
| 30 Mar 2026filed 31 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $786K1,300 at $604.64 | filing |
| 4 Mar 2026filed 5 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,39520 at $119.76 | filing |
| 4 Mar 2026filed 5 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,80320 at $490.17 | filing |
| 4 Mar 2026filed 5 Mar 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —20 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —20 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,39520 at $119.76 | filing |
| 4 Mar 2026filed 5 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,80320 at $490.17 | filing |
| 25 Feb 2026filed 25 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $120K1,000 at $119.76 | filing |
| 25 Feb 2026filed 25 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $520K1,000 at $520.00 | filing |
| 25 Feb 2026filed 25 Feb 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 25 Feb 2026filed 25 Feb 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 25 Feb 2026filed 25 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $120K1,000 at $119.76 | filing |
| 25 Feb 2026filed 25 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $520K1,000 at $520.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Contrasting Xenon Pharmaceuticals (NASDAQ:XENE) and United Therapeutics (NASDAQ:UTHR)UTHR · dailypolitical.com · 18 Oct 2026United Therapeutics (NASDAQ: UTHR) general counsel sells 8,300 shares under planUTHR · themarketsdaily.com · 17 Oct 2026Head to Head Survey: Xenon Pharmaceuticals (NASDAQ:XENE) vs. United Therapeutics (NASDAQ:UTHR)UTHR · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Christopher Causey; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.